Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

VRTX - VERTEX PHARMACEUTICALS INC / MA


488.29
2.570   0.526%

Share volume: 1,198,359
Last Updated: 03-07-2025

PREVIOUS CLOSE
CHG
CHG%

$485.72
2.57
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2023 06-30-2023 09-30-2023 12-31-2023 03-31-2024 06-30-2024 09-30-2024 12-31-2024
Fiscal Quarter Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Report Date 05-02-2023 08-02-2023 11-07-2023 02-15-2024 05-07-2024 08-02-2024 11-05-2024 02-13-2025
Total revenue 2.375 B 2.493 B 2.484 B 2.518 B 2.691 B 2.646 B 2.772 B 2.912 B
Cost of revenue 266.900 M 308.600 M 318.700 M 368.000 M 342.600 M 371.900 M 392.600 M 423.400 M
Gross profit 2.108 B 2.185 B 2.165 B 2.150 B 2.348 B 2.274 B 2.379 B 2.489 B
    3.64% -0.91% -0.70% 9.22% -3.16% 4.64% 4.59%  
Operating expenses 983.700 M 1.048 B 1.074 B 1.194 B 1.132 B 1.339 B 1.263 B 1.464 B
Selling general and admin 241.100 M 262.600 M 263.800 M 369.100 M 342.700 M 372.200 M 371.800 M 377.600 M
Research and development 742.600 M 785.700 M 810.000 M 824.600 M 789.100 M 966.600 M 890.900 M 1.086 B
Total expenses 1.251 B 1.357 B 1.393 B 1.562 B 1.474 B 1.711 B 1.263 B 1.463 B
    8.50% 2.62% 12.15% -5.59% 16.03% -26.17% 15.80%  
Operating income 1.124 B 1.136 B 1.091 B 956.000 M 1.216 B 934.900 M 1.116 B 1.026 B
Ebit 1.124 B 1.136 B 1.091 B 956.000 M 1.216 B 934.900 M 1.099 B 1.011 B
Pretax income 891.500 M 1.162 B 1.179 B 1.148 B 1.279 B -3.391 B 1.224 B 1.137 B
    30.29% 1.52% -2.68% 11.46% -365.12% -136.10% -7.16%  
Income tax 191.700 M 245.800 M 143.900 M 178.800 M 179.500 M 202.400 M 178.700 M 223.500 M
Net income basic 699.800 M 915.700 M 1.035 B 968.800 M 1.100 B -3.594 B 0.000 0.000
    30.85% 13.06% -6.42% 13.50% -426.81% 100.00%    
Net income 699.800 M 915.700 M 1.035 B 968.800 M 1.100 B -3.594 B 1.045 B 913.000 M
    30.85% 13.06% -6.42% 13.50% -426.81% 129.09% -12.67%